Atlas Trials

Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

Clinical trial NCT00096005 · TERMINATED

Trial details

NCT number
NCT00096005
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Adult Grade III Lymphomatoid GranulomatosisAIDS-related Peripheral/Systemic LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell LymphomaRecurrent Adult Diffuse Small Cleaved Cell LymphomaRecurrent Adult Grade III Lymphomatoid GranulomatosisRecurrent Adult Hodgkin Lymphoma
Start date
2004-11-01
Primary completion
2010-03-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.